PMV Pharmaceuticals logo

PMV Pharmaceuticals

PMVP | NASDAQ
Chart Builder DCF Calculator
$1.19
-$0.08 (-6.30%)
At close: Nov 16, 2026, 4:00 PM ET
$1.20
+$0.01 (+0.84%)
After-hours: Nov 16, 2026, 7:09 PM ET
-6.30%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
23.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #953/1021 (Top 93%)

Key Statistics

Market Data

Market Cap $78.81M
1D Range
1.18 1.30
52W Range
1.02 1.80

Valuation (TTM)

PE -0.77
PB 1.38
EV/EBITDA 0.32

Valuation (NTM)

Forward PE N/A
Forward PEG 0.06
Price Target $5.00
Loading financial charts...

Profile

PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. T...

Sector Healthcare
Industry Biotechnology
Employees 54
IPO Date Sep 25, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$5.00
Upside
+320.17%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.